Bookmark

Add to MyYahoo RSS

Keryx Biopharmaceuticals News

News on Keryx Biopharmaceuticals (Ticker: KERX) continually updated from thousands of sources around the net.

Friday Aug 15 | AmericanBankingNews.com

Keryx Biopharmaceuticals Given Average Rating of "Buy" by Analysts

Shares of Keryx Biopharmaceuticals have been given a consensus recommendation of "Buy" by the twelve ratings firms that are presently covering the company, AnalystRatings.NET reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Aug 14, 2014

GuruFocus.com

Seth Klarman's The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, ...

Legendary value investor, hedge fund manager Seth Klarman just reported his second quarter portfolio.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Semiconductors, RF Micro Devices, Electronics, Cable & Satellite, Telecom, ViaSat, Trucking, Boyd Bros Transportation, Transportation, TriQuint Semiconductor, Micron Technology

Wed Aug 13, 2014

AmericanBankingNews.com

FBR Capital Markets Initiates Coverage on Keryx Biopharmaceuticals

The firm set a "market perform" rating on the stock. Keryx Biopharmaceuticals traded up 1.58% during mid-day trading on Wednesday, hitting $16.76.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Aug 11, 2014

AmericanBankingNews.com

Keryx Biopharmaceuticals Given Consensus Recommendation of "Buy" by Analysts

Keryx Biopharmaceuticals has been given a consensus rating of "Buy" by the eleven ratings firms that are covering the stock, Analyst Ratings News reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Aug 08, 2014

AmericanBankingNews.com

Keryx Biopharmaceuticals Given New $30.00 Price Target at Mizuho

Mizuho's target price would suggest a potential upside of 90.84% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Aug 07, 2014

Seeking Alpha

Portfolio Report Card: A Retirement Portfolio Weighed Down By Cost

What is the optimal investment portfolio? Is it the one that contains the hottest performing stocks and funds? Actually, it's the portfolio that perfectly represents a person's psychology, life circumstances, financial needs, and future goals.

Comment?

Related Topix: Personal Finance, Retirement, Mutual Funds, Apple, Startups, Biotech, Medicine, Healthcare Industry

Hispanic Business

Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results

"As we prepare to complete the transition to a commercial-stage company, we have added a wealth of talent to the organization, most recently with the hiring of our regional sales directors.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Tue Aug 05, 2014

BioSpace

Keryx Biopharmaceuticals To Host Conference Call On Second Quarter 2014 Financial Results

Keryx Biopharmaceuticals, Inc. , a biopharmaceutical company focused on bringing innovative therapies to market for patients suffering from renal disease, today announced that a conference call will be held on Thursday, August 7, 2014 at 8:00 a.m. EDT to discuss results for the second quarter of 2014 and provide an update on the business.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration

Wed Jul 30, 2014

Seeking Alpha

Keryx Should Move Substantially In The Next Two Months

Keryx is a small biotech company with the license to a novel treatment for chronic kidney disease that the FDA is reviewing, with a goal date of September 7th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Nephrology, Dialysis, Health, Kidney Cancer

Mon Jul 28, 2014

Medical News Today

Long-term Phase 3 study results for Zerenex (ferric citrate) published

Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Health

Thu Jul 24, 2014

Newswise

Ferric Citrate May Reduce Dialysis Patients' Need for Multiple Medications

A medication called ferric citrate may reduce dialysis patients' need to take multiple drugs that treat complications related to kidney disease.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Benzinga

Keryx Announces Zerenex LT Phase 3 Results Shows 'Highly ...

Keryx Biopharmaceuticals, Inc. announced the publication of results from the long-term, randomized, active control Phase 3 study of Zerenex , the Company's investigational oral ferric iron-based phosphate binder, for the treatment of hyperphosphatemia in patients with end-stage renal disease on dialysis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration

Reuters

Keryx drug improves phosphorus, iron in kidney patients -trial

A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••